TGY2IT
VKTX icon

Timothy G. Youngquist 2020 Irrevocable Trust’s Viking Therapeutics VKTX Stock Holding History

Timothy G. Youngquist 2020 Irrevocable Trust’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6M Buy
271,849
+159,349
+142% +$5.15M 2.08% 8
2026
Q1 		$3.66M Hold
112,500
– – 1.58% 16
2025
Q4 		$3.96M Buy
+112,500
New +$3.99M 2.9% 14

Other funds holding VKTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Timothy G. Youngquist 2020 Irrevocable Trust's VKTX Position: Q2 2026 in Review

Timothy G. Youngquist 2020 Irrevocable Trust increased its Viking Therapeutics (VKTX) stake by 142% in Q2 2026, buying an estimated $5.15M and bringing the position to 271,849 shares worth $10.6M. The position accounts for 2.08% of the portfolio, ranked #8.

Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in VKTX in Q4 2025 and has held it in 3 quarters since. 195 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Timothy G. Youngquist 2020 Irrevocable Trust held 271,849 shares of Viking Therapeutics worth $10.6M as of Q2 2026.
  • Timothy G. Youngquist 2020 Irrevocable Trust bought 159,349 Viking Therapeutics shares in Q2 2026, an estimated $5.15M.
  • Viking Therapeutics made up 2.08% of Timothy G. Youngquist 2020 Irrevocable Trust's portfolio in Q2 2026, its #8 holding.
  • Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in Viking Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 195 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Timothy G. Youngquist 2020 Irrevocable Trust's 13F filing for Q2 2026, filed 7 Aug 2026.